Mereo BioPharma Group (LTS:0A9G) Other Gross PPE : $1.98 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mereo BioPharma Group Other Gross PPE?

Mereo BioPharma Group's Other Gross PPE for the quarter that ended in Sep. 2024 was $1.98 Mil.

Mereo BioPharma Group's quarterly Other Gross PPE declined from Mar. 2024 ($2.11 Mil) to Jun. 2024 ($1.02 Mil) but then increased from Jun. 2024 ($1.02 Mil) to Sep. 2024 ($1.98 Mil).

Mereo BioPharma Group's annual Other Gross PPE declined from Dec. 2021 ($1.39 Mil) to Dec. 2022 ($1.10 Mil) and declined from Dec. 2022 ($1.10 Mil) to Dec. 2023 ($1.01 Mil).

Mereo BioPharma Group Other Gross PPE Historical Data

The historical data trend for Mereo BioPharma Group's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Other Gross PPE Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

1.71

2.00

1.39

1.10

1.01

Mereo BioPharma Group Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Gross PPE	Get a 7-Day Free Trial															-	1.01	2.11	1.02	1.98

Mereo BioPharma Group Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (LTS:0A9G) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

MREO:USA MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines